• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Thrombolysis After 'Wake-Up Stroke' FeasibleThrombolysis After 'Wake-Up Stroke' Feasible
Preliminary findings add to increasing data suggesting that thrombolytic treatment in patients who wake up with stroke symptoms is feasible, beneficial. Medscape Medical News
Source: Medscape Medical News Headlines - October 27, 2014 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Aspirin can cut stroke and heart attack risk by a third
TAKING aspirin can slash the risk of blood clots, heart attacks, stroke and deep vein thrombosis by a third, claims a study.
Source: Daily Express - Health - August 26, 2014 Category: Consumer Health News Source Type: news

Can a 'microwave helmet' really detect strokes?
Conclusion This study has shown that haemorrhagic strokes could potentially be distinguished from ischaemic strokes by analysing microwave scattering measurements. While the two types of stroke can already be accurately diagnosed by CT or MRI scans in hospital, the “microwave helmet” development is important because it could potentially be used before someone arrives in hospital. This would avoid any time delay and allow people with ischaemic stroke to receive the anti-clotting medication that they need as soon as possible, potentially reducing the extent of damage the stroke causes. The technique isn’t perfect ye...
Source: NHS News Feed - June 17, 2014 Category: Consumer Health News Tags: Heart/lungs Medical practice Source Type: news

NICE: 'schools should provide morning-after pill'
Conclusion Everyone makes mistakes, but if you find yourself relying on the morning-after pill as a regular method of contraception, you may want to speak to a healthcare professional about what would be the most suitable form of ongoing contraception for you to use. This could include methods that do not involve needing to take a daily pill, such as contraceptive patches, injections or an implant. However, none of these methods will protect you against sexually transmitted infections (STIs). Condoms are cheap, free of side effects and they will protect you against STIs such as chlamydia. For more information about your ...
Source: NHS News Feed - March 26, 2014 Category: Consumer Health News Tags: QA articles Pregnancy/child Source Type: news

Stroke risk 'higher at start of warfarin treatment'
Conclusion This study has found that warfarin was associated with an increased risk of ischaemic stroke during the first 30 days of treatment. After 30 days of treatment, warfarin was associated with a decreased risk of stroke. However, this study has a number of limitations that should be considered: All information was from patient records, which means that it wasn't subject to recall bias, but the information may not be complete – we do not know if, for example, people took the medication they were prescribed. There may be other factors (confounders) that explain the association seen. In particular, the ba...
Source: NHS News Feed - December 19, 2013 Category: Consumer Health News Tags: Heart/lungs Medication Source Type: news

Scan could detect those on brink of heart attack
Conclusion This is a valuable study which shows the promise of using PET-CT with radioactively labelled sodium fluoride (NaF) as a way of identifying fatty deposits in the heart arteries that could be at risk of rupturing and causing a heart attack. The results confirmed that the marker used in this study (NaF) was better than the chemical marker normally used in PET-CT scans (FDG). The technique has the principal value of being a non-invasive technique compared with coronary angiography, which is the standard method used to look at blockages in heart arteries. As it does not involve surgical intervention, this could ha...
Source: NHS News Feed - November 11, 2013 Category: Consumer Health News Tags: Heart/lungs Medical practice Source Type: news

CEE Raises Venous Thrombosis Risk vs Estradiol for Oral HRTCEE Raises Venous Thrombosis Risk vs Estradiol for Oral HRT
There was also a trend of increased MI risk but no signal of increased risk for ischemic stroke in the observational look at ischemic risk factors in women on HRT. Heartwire
Source: Medscape Today Headlines - October 1, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

UNC researchers find promising platelet protein that could offer new angle for developing drugs to prevent thrombosis
Platelets, which allow blood to clot, are at the heart of numerous cardiovascular problems, including heart attacks and stroke. New research has uncovered a key platelet protein that could offer a new angle for developing drugs to prevent thrombosis, or dangerous blood clots, in patients who are at high risk such as those with atherosclerosis or a history of heart problems...
Source: Health News from Medical News Today - September 4, 2013 Category: Consumer Health News Tags: Vascular Source Type: news

Earlier the Better for Stroke Treatment (CME/CE)
(MedPage Today) -- The earlier within the recommended treatment window that intravenous thrombolytic therapy was administered, the better the outcomes following ischemic stroke, an observational study showed.
Source: MedPage Today State Required CME - August 22, 2013 Category: Consumer Health News Source Type: news

Waking up to new treatments for stroke - WAKE-UP trial starts in the UK
WAKE-UP - a large European clinical trial to test whether current 'clot dissolving' treatments can be used in people who wake up with the symptoms of stroke enrolled the first UK patients at the Southern General Hospital this week. Every year about two million patients have a stroke in the EU. Up to 20 per cent of stroke patients wake up with stroke symptoms so the time the stroke started is unknown. This makes patients ineligible for the only approved treatment for acute stroke- the delivery the thrombolytic or 'clot dissolving' drug rtPA...
Source: Health News from Medical News Today - July 29, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Drugs to be offered to women at high risk of breast cancer
The National Institute of Health and Care Excellence (NICE) has today released updated guidelines on the care of women who are at increased risk of breast cancer due to their family history. One of the main changes to the original guidance from 2004 is that NICE now recommends drug treatment with tamoxifen or raloxifene to reduce risk of breast cancer in a specific group of women who are at high risk of breast cancer and have not had the disease. They say that these treatments could help prevent breast cancer in about 488,000 women aged 35 years and older. The updated guideline has also made changes to the recommende...
Source: NHS News Feed - June 25, 2013 Category: Consumer Health News Tags: Cancer Medical practice QA articles Source Type: news

Clot Busters Offer Long-Term Benefits (CME/CE)
(MedPage Today) -- Stroke patients continued to benefit from thrombolytic therapy for at least a year and a half after treatment, long-term follow-up from a randomized trial showed.
Source: MedPage Today State Required CME - June 21, 2013 Category: Consumer Health News Source Type: news

More Benefits of Early tPA in Stroke More Benefits of Early tPA in Stroke
Earlier thrombolytic treatment was associated with both lower mortality and fewer symptomatic intracranial hemorrhages, as well as higher rates of independent ambulation at discharge and discharge to home. Medscape Medical News
Source: Medscape Today Headlines - June 20, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Earlier Treatment Following Stroke Onset Associated With Reduced Risk Of In-Hospital Death, Higher Rate Of Discharge To Home
In a study that included nearly 60,000 patients with acute ischemic stroke, thrombolytic treatment (to help dissolve a blood clot) that was started more rapidly after symptom onset was associated with reduced in-hospital mortality and intracranial hemorrhage and higher rates of independent walking ability at discharge and discharge to home, according to a study in the June 19 issue of JAMA. "Intravenous (IV) tissue-type plasminogen activator (tPA) is a treatment of proven benefit for select patients with acute ischemic stroke as long as 4.5 hours after onset...
Source: Health News from Medical News Today - June 20, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Speed Vital For Stroke Patients' Survival
The sooner stroke patients receive thrombolytic treatment, the lower their risk of in-hospital mortality and intracranial hemorrhage, says a new study published in JAMA (Journal of the American Medical Association). In addition, the prompter the treatment, the higher the rate of walking ability at discharge. Intravenous (IV) tissue-type plasminogen activator (tPA) is a form of treatment proven to help stroke patients within 4.5 hours of onset of symptoms...
Source: Health News from Medical News Today - June 19, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Pages: 1  2  3  4